- Home
- CHKP vs GH Comparison
CHKP vs GH Comparison
Compare CHKP & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHKP | GH |
|---|---|---|
| Founded | 1993 | 2011 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1B | 12.7B |
| IPO Year | 1997 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CHKP | GH |
|---|---|---|
| Price | $133.28 | $132.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 19 |
| Target Price | ★ $199.50 | $119.79 |
| AVG Volume (30 Days) | 2.0M | ★ 2.1M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.74 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $982,021,000.00 |
| Revenue This Year | $8.31 | $33.30 |
| Revenue Next Year | $6.03 | $28.27 |
| P/E Ratio | $17.05 | ★ N/A |
| Revenue Growth | N/A | ★ 32.88 |
| 52 Week Low | $112.23 | $39.70 |
| 52 Week High | $233.78 | $133.66 |
Technical Indicators
Market Signals| Indicator | CHKP | GH |
|---|---|---|
| Relative Strength Index (RSI) | 56.45 | 81.99 |
| Support Level | $112.29 | $97.16 |
| Resistance Level | $151.85 | N/A |
| Average True Range (ATR) | 4.35 | 6.18 |
| MACD | 2.16 | 3.54 |
| Stochastic Oscillator | 95.36 | 95.56 |
Price Performance
Historical ComparisonAbout CHKP Check Point Software Technologies Ltd.
Check Point Software Technologies is a pure-play cybersecurity vendor. The company offers solutions for network, endpoint, cloud, and mobile security in addition to security management. Check Point, a software specialist, sells to enterprises, businesses, and consumers. Around 50% of revenue is generated in Europe, the Middle East, and Africa, 40% from the Americas, and 10% from the Asia-Pacific region. The firm, based in Tel Aviv, Israel, was founded in 1993 and has about 5,000 employees.
About GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.